n/a
Abstract Title:

Palmitoylethanolamide (PEA) in the treatment of neuropathic pain: a case study.

Abstract Source:

Nutr Health. 2021 Jul 21:2601060211019669. Epub 2021 Jul 21. PMID: 34289728

Abstract Author(s):

Despina Kamper

Article Affiliation:

Despina Kamper

Abstract:

BACKGROUND: Neuropathic pain is a condition caused by a lesion or disease of the somatosensory nervous system. It may present as debilitating pain with a sensation of burning and electric-like symptoms and is often difficult to manage effectively. Although pharmacological medications are the first line of treatment, multidisciplinary teams are sometimes required to provide appropriate treatment to improve quality of life and overall wellbeing.

AIM: The aim of this study is to present a case of post herpetic neuralgia relieved successfully by the compound palmitoylethanolamide (PEA) - a natural alternative to pharmacological pain relief.

METHODS: We present the case of a 67 year-old male with ongoing post-herpetic neuralgia, over a 3-year period, as a result of complications from shingles (herpes zoster). Previous studies on the relationship between PEA and neuropathy were reviewed, with an attempt to discuss the possible underlying mechanism of PEA on neuropathic pain.

RESULTS: PEA demonstrated effective pain relief within 48 hours at an administered daily dose of 900 mg (10 mg/kg).

CONCLUSIONS: PEA may offer a valid nutraceutical treatment for practitioners.

Study Type : Human: Case Report

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.